跳至主要内容
临床试验/NCT05991219
NCT05991219招募中不适用

Screening and Secondary Prevention Rheumatic Heart Disease

National Institute of Cardiovascular Diseases, Pakistan1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2022年9月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
1
主要终点
Rheumatic heart disease

研究概览

简要总结

After basic clinical screening including history and physical, Point of care ultrasound will be performed to look at Mitral, Aortic and Tricuspid Valves for regurgitation or stenosis. For patients with confirmed Rheumatic heart disease (RHD), treatment and referral depending on stage of disease. Antibiotic prescription could be shifted to community health workers delivering preventive medications via practical clinical algorithms, diagnostic tools, availability of appropriate antibiotics, and supportive supervision. Patients will have repeat imaging at 2 years and 5 years to look at the outcome of delayed progression of valve disease.

详细描述

Screening for RHD should be carried out since it is a major health concern that has been shown to have a treatable and detectable latent stage that can be diagnosed using a simple sensitive test (point of care ultrasound) and early treatment (secondary prevention using antibiotic prophylaxis) can provide a better outcome (slow progression of disease) in a cost effective way. The investigators aim to study the Incidence and Prevalence of RHD in community and school settings and aim to intervene depending on the stage the disease is picked up in.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
10 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Rural communities in Sindh

排除标准

  • Refused to participate in the study

结局指标

主要结局

Rheumatic heart disease

时间窗: At the time of screening echocardiogram

Number of patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sabha Bhatti

Professor

National Institute of Cardiovascular Diseases, Pakistan

研究点 (1)

Loading locations...

相似试验